← Open Payments lookup

INNA CHERNOGLAZ: Open Payments

NPI 1225226756 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$603 in 29 payments from 12 companies in 2025. Trend: 2023 $855 · 2024 $1,202 · 2025 $603

Food & beverage: $603
CompanyPaymentsAmount
ABBVIE INC.8$151
Novo Nordisk Inc5$110
Esperion Therapeutics, Inc.4$85
Astellas Pharma US Inc2$54
Amgen Inc.2$45
Sumitomo Pharma America, Inc.2$34
Abbott Laboratories1$26
Ardelyx, Inc.1$24
Aimmune Therapeutics, Inc.1$24
Vifor Pharma, Inc.1$19

Products named: NEXLETOL, LINZESS, Ozempic, Veozah, UBRELVY, GEMTESA, CREON, FREESTYLE LIBRE 3.

Industry payments across NY — which companies pay providers there.